PixelLabs
PixelLabs Raises $40M Series B to Transform Biotech
Quick Facts
PixelLabs Raises $40M Series B in Latest Funding Round
PixelLabs has successfully closed a $40M Series B funding round, marking a significant milestone in the company's growth trajectory. The round was led by General Catalyst, with participation from Sequoia Capital.
Company Overview
Founded in 2025 and headquartered in Washington, DC, PixelLabs has established itself in the Biotech space. Leading artificial intelligence infrastructure enabling scalable ML deployment for businesses
With a current valuation of $350M, the company has demonstrated strong market traction and investor confidence.
Investment Details
- Amount Raised: $40M Series B
- Valuation: $350M
- Lead Investor: General Catalyst
Future Outlook
As PixelLabs moves forward with its expanded funding, the company is well-positioned to capitalize on market opportunities and drive innovation in the biotech space.
Key Investors
About the Author
Related Company Reports
HorizonStudio Raises $100M Growth to Transform Biotech
HorizonStudio has secured $100M Growth in funding to accelerate growth and innovation. Leading artificial intelligence infrastructure enabling scalable ML deployment for businesses...
StreamData Raises $15M Seed to Transform Biotech
StreamData has secured $15M Seed in funding to accelerate growth and innovation. Leading artificial intelligence infrastructure enabling scalable ML deployment for businesses...
NeuralTech Raises $100M Growth to Transform Biotech
NeuralTech has secured $100M Growth in funding to accelerate growth and innovation. Leading AI-powered analytics platform transforming data into actionable business insights...